Class 4 caution in use-Tramadol 50 mg capsules & PR capsules

Morningside Healthcare Limited has informed the MHRA of a packaging issue identified in batch MRA2303 of Tramadol Hydrochloride Morningside 50 mg Prolonged-Release Capsules and batch MRF2301 of Tramadol Hydrochloride 50 mg Capsules.

MHRA Drug alert date: 27th November 2024

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-morningside-healthcare-limited-tramadol-hydrochloride-50-mg-capsules-and-tramadol-hydrochloride-morningside-50-mg-prolonged-release-capsules-el-24-a-slash-57

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries and reports of missing capsules or blister strips, please email medinfo@aspirepharma.co.uk or telephone 01730231148.

For all stock enquiries, please email mplcustomerservices@morningsidepharm.com or telephone 01730231148.

Class 3 recall-Baclofen 10mg/5ml Oral Solution

Syri Limited, T/A SyriMed is recalling this batch of product as a precautionary measure due to crystallisation observed over time in the oral solution.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-syri-limited-t-slash-a-syrimed-baclofen-10mg-slash-5ml-oral-solution-el-24-a-slash-56?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=2211a202-bd3d-4594-97b7-810fe36e857b&utm_content=immediately

Further Information

For medical information enquiries please email medinfo@syrimed.co.uk, or telephone +44 (0) 330 1359 422.

For stock control enquiries please email syriwholesale@bnsthamelabs.com.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

field saftey notice-Silvercel And Tegaderm dressings

We have received a field safety notice from Advanced Medical Solutions (AMS) regarding batches of Silvercel and Tegaderm dressings

Date of recall:19/11/24

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Entyvio 108mg solution for injection in pre-filled syringe

Takeda UK Limited has informed the MHRA that there is an error in the Patient Information Leaflet for specified batches of Entyvio 108mg pre-filled syringes.

MHRA Drug alert date: 18th November 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-takeda-uk-limited-entyvio-108mg-solution-for-injection-in-pre-filled-syringe-el-24-a-slash-55?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=434da6dd-accb-44a3-8388-8e2c828f01ed&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please Email medinfoemea@takeda.com or telephone 03333 000 181

For stock control enquiries please Email ukie.supplychain@takeda.com

Company-led recall: EXS Delay Spray Plus

LTC Healthcare has informed the MHRA that they have been selling a medicinal product containing lidocaine without authorisation from the MHRA.

MHRA Drug alert date: 13th November 2024

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/company-led-medicines-recall-leeds-trading-company-ltc-ltd-t-slash-a-ltc-healthcare-exs-delay-spray-plus-clmr-24-a-slash-01?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=f8d41c6d-9823-4127-9e84-7c0ff605722f&utm_content=immediately

Further Information

For medical information enquiries, please contact Andy Taylor, Managing Director:

Email: andy@ltchealthcare.co.uk

Telephone: 01423 326687

For stock information enquiries, please contact Andy Taylor, Managing Director:

Email: andy@ltchealthcare.co.uk

Telephone: 01423 326687

Class 4 caution in use-Omeprazole 40mg Powder for solution for infusion

Generics (U.K.) Limited has informed the MHRA that the Patient Information Leaflet (PIL) packaged in specific batches of Omeprazole 40 mg Powder for solution for infusion do not contain the most up to date safety information.

MHRA Drug alert date: 12th November 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-viatris-uk-healthcare-ltd-omeprazole-40-mg-powder-for-solution-for-infusion-el-24-a-slash-54?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=b6521847-f0ea-4fbc-adc8-ba74059c9b3b&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information and stock control queries please contact:

Viatris UK Healthcare Limited Medical Information at +44 (0)1707 853 000 (select option 1) or info.uk@viatris.com. Customer Services can be reached at +44 (0)1707 853 000 (select option 2).

Class 4 caution in use-Zoledronic acid 4mg/5ml Solution

Ennogen Healthcare Limited has identified that action had not been taken to ensure the Patient Reminder Card (PRC) was distributed alongside the packs of product as part of the approved Additional Risk Minimisation Measures (RMM).

MHRA Drug alert date: 7th November 2024

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-ennogen-healthcare-limited-zoledronic-acid-ennogen-4mg-slash-5ml-concentrate-for-solution-for-infusion-el-24-a-slash-53?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=ae0d646e-30a4-4189-8027-c36d2c450c0b&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please contact MedicalInformation@ennogen.com

For stock control enquiries please telephone +44 (0)1322 629220

Class 2 recall-Labetalol 200mg tablets

Tillomed Laboratories Limited is recalling one batch of Labetalol 200mg Tablets as a precautionary measure due to potential mix-up at the manufacturing site.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-tillomed-laboratories-limited-labetalol-200mg-tablets-el-24-a-slash-52?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=2e33e9ba-323e-48e8-a188-eb6c601fda3b&utm_content=immediately

Further Information

For all medical enquiries, please contact Tillomed Laboratories Limited by email at either medical.information@tillomed.co.uk or PVUK@tillomed.co.uk, or telephone 0800 9706115.

For enquiries relating to stock returns please email Tillomed Laboratories Limited customer services customer.service@tillomed.com or telephone 01480 402 400.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Parasolve 500mg

Kent Pharma UK has identified an error in the Patient Information Leaflet (PIL) for Paracetamol 500mg Effervescent Tablets.

MHRA Drug alert date: 28th October 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-kent-pharma-uk-parasolve-paracetamol-500mg-effervescent-tablets-el-24-a-slash-51?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=5872b8d6-4416-46db-b971-7547e5419b92&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please contact medical@kent-athlone.com

For stock control enquiries please contact customer.service@kent-athlone.com

Class 2 recall-Phenobarbital tabs 15mg Bristol

Bristol Laboratories Ltd. are recalling one batch of Phenobarbital Bristol Labs 15mg Tablets as a precautionary measure due to the potential of contamination of small metallic particles within the tablets.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-bristol-laboratories-ltd-phenobarbital-bristol-labs-15mg-tablets-el-24-a-slash-50?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=7ae4cb12-a098-4a7b-84d5-cf21de226896&utm_content=immediately

Further Information

For medical information enquiries please contact: Notifications@bristol-labs.co.uk

For stock control enquiries please contact: Notifications@bristol-labs.co.uk

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.